Loading...

PE anti-mouse CD11c Antibody PE anti-mouse CD11c Antibody

Pricing & Availability
Clone
N418 (See other available formats)
Regulatory Status
RUO
Other Names
αX integrin, integrin αX chain, CR4, p150, ITGAX
Isotype
Armenian Hamster IgG
Ave. Rating
Submit a Review
Product Citations
publications
N418_A_PE_Pos_071006.jpg
C57BL/6 mouse splenocytes stained with APC anti-mouse I-A/I-E (clone M5/114.15.2) and PE N418 (top) or PE Armenian hamster IgG isotype control (bottom)
  • N418_A_PE_Pos_071006.jpg
    C57BL/6 mouse splenocytes stained with APC anti-mouse I-A/I-E (clone M5/114.15.2) and PE N418 (top) or PE Armenian hamster IgG isotype control (bottom)
  • N418_B_PE_Neg_071006.jpg
    C57BL/6 mouse splenocytes stained with APC anti-mouse I-A/I-E (clone M5/114.15.2) and PE N418 (top) or PE Armenian hamster IgG isotype control (bottom)
Compare all formats See PE spectral data
Cat # Size Price Quantity Check Availability Save
117308 200 µg SEK1538
Check Availability


Need larger quantities of this item?
Request Bulk Quote
117307 50 µg SEK605
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD11c is a 150 kD glycoprotein also known as αX integrin, CR4, and p150. CD11c forms a αXβ2 heterodimer with β2 integrin (CD18). It is primarily expressed on dendritic cells, NK cells, a subset of intestinal intraepithelial lymphocytes (IEL), and some activated T cells. The αXβ2 integrin plays an important role in cell-cell contact by binding its ligands: iC3b, fibrinogen, and CD54.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Armenian Hamster
Immunogen
Mouse spleen dendritic cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The CD11c antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for other applications.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Additional reported applications (for the relevant formats) include: immunoprecipitation3, immunohistochemical staining of acetone-fixed frozen sections3, immunofluorescence microscopy5, 9 (Alexa Fluor® 488 conjugated N418 was used for IHC in frozen sections10), and spatial biology (IBEX)22,23.

Application References
  1. Granucci F, et al. 1997. J. Immunol. 159:1794.
  2. Stokes RW, et al. 1998. J. Immunol. 160:5514.
  3. Metlay JP, et al. 1990. J. Exp. Med. 171:1753. (IHC, IP)
  4. Ma XT, et al. 2006. Cancer Research 66:1169.
  5. Chin RK, et al. 2006. J. Immunol. 177:290. (IF)
  6. Cervantes-Barragan L, et al. 2007. Blood 109:1131. (FC) PubMed
  7. Turnquist HR, et al. 2007. J. Immunol. 178:7018. (FC) PubMed
  8. Benson MJ, et al. 2007. J. Exp. Med. doi:10.1084/jem.20070719. (FC) PubMed
  9. You Y, et al. 2009. J. Immunol. 182:7343. (IF) PubMed
  10. Roland CL, et al. 2009. Mol. Cancer Res. 8:1761. (IHC, FC) PubMed
  11. Wikstrom M, et al.2006. J. Immunol. 177:913. PubMed
  12. Pericolini E, et al. 2008. J. Leukocyte Biol. 83:1286. PubMed
  13. Randall LM, et al. 2008. Infect. Immun.76:3312. PubMed
  14. Fahlen-Yrild L, et al. 2009. J. Immunol. 183:5032. PubMed
  15. Osterholzer JJ, et al. 2009. J. Immunol. 183:8044. PubMed
  16. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  17. Eisenach PA, et al. 2010. J Cell Sci. 123:4182. PubMed
  18. Leppin K, et al. 2014. Invest. Ophthalmol. Vis. Sci. 55:3603. PubMed
  19. Sakai F, et al. 2014. PLoS One. 9:105370. PubMed
  20. Gibbins JD, et al. 2014. Blood. 124:2953. PubMed
  21. White CE, et al. 2015. J Immunol. 194:697. PubMed
  22. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
  23. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  24. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Hou X, et al. 2020. Cell Reports. 28(1):172-189.e7.. PubMed
  2. Lin C et al. 2019. Immunity. 50(1):137-151 . PubMed
  3. Xiong Y, et al. 2020. J Nanobiotechnology. 18:66. PubMed
  4. Liang J, et al. 2021. Cancer Manag Res. 13:6977. PubMed
  5. Alam A, et al. 2022. Cancer Cell. 40:153. PubMed
  6. Du Y, et al. 2022. J Exp Med. 219: . PubMed
  7. Yu C, et al. 2022. Invest Ophthalmol Vis Sci. 63:1. PubMed
  8. Marquardt RM, et al. 2022. Int J Mol Sci. 23: . PubMed
  9. Zhao Z, et al. 2022. Adv Sci (Weinh). 9:e2201293. PubMed
  10. Silva Pereira S, et al. 2022. Elife. 11: . PubMed
  11. Zhang Z, et al. 2022. Mol Nutr Food Res. 66:e2200300. PubMed
  12. Zhu J, et al. 2022. Nat Commun. 13:7466. PubMed
  13. Hao J, et al. 2022. Cell Rep. 41:111804. PubMed
  14. An HW, et al. 2022. Cell Rep. 41:111878. PubMed
  15. Guo R, et al. 2022. Cells. 12: . PubMed
  16. Kulkarni R, et al. 2023. Life Sci Alliance. 6: . PubMed
  17. Kodali S, et al. 2022. J Immunol. 208:1085. PubMed
  18. Friedman D, et al. 2022. J Immunol. 208:1845. PubMed
  19. Reticker-Flynn NE, et al. 2022. Cell. 185:1924. PubMed
  20. Gao T, et al. 2022. Cell Biochem Biophys. 80:579. PubMed
  21. Lin J, et al. 2022. Adv Sci (Weinh). 9:e2202633. PubMed
  22. Harapas CR, et al. 2022. Sci Immunol. 7:eabi4611. PubMed
  23. Boroumand P, et al. 2022. Elife. 11:. PubMed
  24. Ou W, et al. 2023. Nat Commun. 14:392. PubMed
  25. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  26. Wang Y, et al. 2023. EBioMedicine. 90:104480. PubMed
  27. Cheong LY, et al. 2023. Nat Commun. 14:1213. PubMed
  28. Yin C, et al. 2023. Sci Rep. 13:3903. PubMed
  29. Fu S, et al. 2023. Nat Commun. 14:2248. PubMed
  30. Kaltenbach L, et al. 2023. Nat Immunol. 24:915. PubMed
  31. Yu L, et al. 2023. Front Oncol. 13:1174713. PubMed
  32. Hsieh MS, et al. 2023. NPJ Vaccines. 8:82. PubMed
  33. Zhang AQ, et al. 2023. Nat Biomed Eng. . PubMed
  34. Tseng JC, et al. 2023. Int J Biol Sci. 19:2648. PubMed
  35. Lee T, et al. 2014. Mol Biol Cell. 25:583. PubMed
  36. Koyama M, et al. 2015. J Exp Med. 212: 1303 - 1321. PubMed
  37. Zhao Z, et al. 2021. Nat Commun. 12:4355. PubMed
  38. Grigsby SM, et al. 2021. Cancers (Basel). 13:. PubMed
  39. Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed
  40. Tseng K, et al. 2009. J Immunol. 182:4590. PubMed
  41. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  42. Lee S, et al. 2021. JCI Insight. 6:. PubMed
  43. Fan L, et al. 2021. Cancers (Basel). 13:. PubMed
  44. Zhang R, et al. 2021. Cell Mol Immunol. 18:1222. PubMed
  45. Du J, et al. 2020. Developmental Cell. 55(6):737-753.e7. PubMed
  46. Naito Y, et al. 2019. American Journal of Physiology-Renal Physiology. 318(1):F238-F247. PubMed
  47. Jackson A, et al. 2014. J Leukoc Biol. 92:609. PubMed
  48. Blecher-Gonen R, et al. 2019. Cell Syst. 8:109. PubMed
  49. Baptista AP et al. 2019. Immunity. 50(5):1188-1201 . PubMed
  50. Lee H, et al. 2020. Cell Metabolism. 31(4):822-836. PubMed
  51. Kunimura K, et al. 2020. Cell Reports. 29(9):2823-2834.e7.. PubMed
  52. Zhang J, et al. 2021. MedComm (Beijing). 2:256. PubMed
  53. Kang S, et al. 2009. Gastroenterology. 137:1391. PubMed
  54. Clark K, et al. 2015. J Autoimmun. Available online 21 August 2015. PubMed
  55. Wu R, et al. 2019. J Cell Mol Med. 24:1684. PubMed
  56. Schmidleithner L et al. 2019. Immunity. 50(5):1232-1248 . PubMed
  57. Shu T, et al. 2022. Eur Respir J. Online ahead of print. PubMed
  58. Cheong SS, et al. 2020. Front Cell Dev Biol. 8:577201. PubMed
  59. Li Q et al. 2018. Immunity. 48(2):258-270 . PubMed
  60. Nakagawa S et al. 2017. Cell host & microbe. 22(5):667-677 . PubMed
  61. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  62. Lees JG, et al. 2020. PLoS One. 15:e0238164. PubMed
  63. Xiong A, et al. 2022. EBioMedicine. 83:104239. PubMed
  64. Hu K, et al. 2015. PLoS One. 10: 0137123. PubMed
  65. Toivonen R, et al. 2016. J Immunol. 196: 4750 - 4759. PubMed
  66. Shemer A, et al. 2020. Immunity. 53(5):1033-1049.e7. PubMed
  67. Brooks JF, et al. 2020. Cytotherapy. 22:436. PubMed
  68. Privratsky JR, et al. 2018. Am J Physiol Renal Physiol. 315:F682. PubMed
  69. Akram KM, et al. 2019. Nat Commun. 10:1178. PubMed
  70. Tran L, et al. 2017. Cancer Immunol Res. 5:1141. PubMed
  71. Wang C, et al. 2017. J Immunol. 10.4049/jimmunol.1700671. PubMed
  72. Li X, et al. 2015. J Immunol. 195: 2710-2721. PubMed
  73. Fujita K, et al. 2019. Proc Natl Acad Sci U S A. 116:14714. PubMed
  74. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  75. Ramos CV, et al. 2020. Cell Reports. 32(3):107910. PubMed
  76. Dane EL, et al. 2022. Nat Mater. 21:710. PubMed
  77. Syed A, et al. 2015. Infect Immun . 83: 3428-3437. PubMed
  78. Ma Y, et al. 2015. J Immunol. 195: 3769 - 3780. PubMed
  79. Chi Z, et al. 2020. Molecular Cell. 80(1):43-58.e7. PubMed
  80. Fulham MA, et al. 2019. Am J Physiol Cell Physiol. 317:C687. PubMed
  81. Benechet AP, et al. 2019. Nature. 574:200. PubMed
  82. Feng T, et al. 2022. Nat Commun. 13:5208. PubMed
  83. Zhang L, et al. 2021. J Immunother Cancer. 9:. PubMed
  84. Li Z, et al. 2022. J Exp Clin Cancer Res. 41:74. PubMed
  85. Wu L, et al. 2022. Theranostics. 12:842. PubMed
  86. Jiao Y, et al. 2021. Crit Care. 25:356. PubMed
  87. Jeong SH, et al. 2021. Nat Commun. 12:4405. PubMed
  88. Carozza JA, et al. 2020. Nat Cancer. 184:1. PubMed
  89. Aegerter H, et al. 2020. Nat Immunol. 0.975694444. PubMed
  90. Galvani E, et al. 2020. Nat Commun. 11:853. PubMed
  91. Wang J, et al. 2021. Nat Commun. 12:6198. PubMed
  92. Friedman DJ, et al. 2021. Cancer Immunol Res. 9:952. PubMed
  93. Glaros V, et al. 2021. Immunity. 54:2005. PubMed
  94. Guo Y, et al. 2022. Nat Commun. 13:6534. PubMed
  95. Ray A, et al. 2015. PLoS One. 10: 0137314. PubMed
  96. Garcia LR, et al. 2021. Nat Commun. 12:3364. PubMed
  97. Park SG, et al. 2021. J Vet Sci. 22:e16. PubMed
  98. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  99. Garo LP, et al. 2019. Cell Rep. 28:3353. PubMed
  100. Miteva K, et al. 2018. Sci Rep. 8:2820. PubMed
  101. Ding Y, et al. 2022. Cell Death Dis. 13:996. PubMed
  102. Yong L, et al. 2022. Nat Commun. 13:4255. PubMed
  103. Pilones KA, et al. 2020. Cancer Immunol Res. 8:1054. PubMed
  104. Reinfeld BI, et al. 2021. Nature. 593:282. PubMed
  105. Toubal A, et al. 2020. Nat Commun. 3755:11. PubMed
  106. Barsoumian HB, et al. 2020. J Immunother Cancer. 8:00. PubMed
  107. Osaka M, et al. 2016. Sci Rep. 6:21391. PubMed
  108. Van Winkle JA et al. 2018. Cell host & microbe. 24(5):665-676 . PubMed
  109. LaFleur MW, et al. 2019. Nat Commun. 10:1668. PubMed
  110. Yang H, et al. 2019. J Neuroinflammation. 16:169. PubMed
  111. Liu S, et al. 2020. Cell Host & Microbe. 26(6):779-794.e8.. PubMed
  112. Vorselen D, et al. 2021. Elife. 10:. PubMed
  113. Dey S, et al. 2020. J Immunother Cancer. 8:. PubMed
  114. Olson M, et al. 2014. J Immunol. 193:5420. PubMed
  115. Zeng W, et al. 2021. STAR Protocols. 2(1):100361. PubMed
  116. De Simone G, et al. 2021. Immunity. :. PubMed
  117. Lim CX, et al. 2020. Cell Rep. 3793:30. PubMed
  118. Choi EW, et al. 2020. Sci Rep. 10:12001. PubMed
  119. López MJ, et al. 2018. Invest Ophthalmol Vis Sci. 59:5671. PubMed
  120. Cohen M et al. 2018. Cell. 175(4):1031-1044 . PubMed
  121. Maulloo CD, et al. 2021. Front Immunol. 12:714842. PubMed
  122. Koikawa K, et al. 2021. Cell. 184:4753. PubMed
  123. Hanihara-Tatsuzawa F, et al. 2014. J Biol Chem. 389:30925. PubMed
  124. Hsu Y, et al. 2017. Biochem Biophys Res Commun.. 10.1016/j.bbrc.2017.10.067. PubMed
  125. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  126. Lebel MÈ, et al. 2020. Nat Commun. 3.051388889. PubMed
  127. Benhamron S, et al. 2012. PLoS One. 7:e35602. PubMed
  128. Li D, et al. 2022. Emerg Microbes Infect. 11:2248. PubMed
  129. Hu Y, et al. 2021. Cell Death Dis. 12:743. PubMed
  130. Rosenbaum SR, et al. 2020. Cell Rep. 30:510. PubMed
  131. Yuan X, et al. 2017. Elife. 6:e29540. PubMed
  132. Wang Y, et al. 2021. Nat Commun. 12:4964. PubMed
  133. Takahashi F, et al. 2022. iScience. 25:104278. PubMed
  134. Wang W, et al. 2021. J Am Heart Assoc. 10:e019142. PubMed
  135. Nahrendorf W, et al. 2021. eLife. 10:00. PubMed
  136. Bi CS, et al. 2020. Cell Prolif. 53:e12827. PubMed
  137. Nechama M, et al. 2018. Nat Commun. 9:1603. PubMed
  138. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  139. Oliveira AC et al. 2017. eLife. 6 pii: e30883. PubMed
  140. Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed
  141. Lu X, et al. 2019. Circ Res. 125:1055. PubMed
  142. Zhang MS, et al. 2022. Nat Commun. 13:954. PubMed
  143. Tuong ZK, et al. 2021. Cell Rep. 37:110132. PubMed
  144. Kataru RP, et al. 2022. Front Aging. 3:864860. PubMed
  145. Al-Barwani F, et al. 2014. PLoS One. 9:104523. PubMed
  146. Holzki J, et al. 2015. J Virol. 89: 9886 - 9895. PubMed
  147. Gamradt P, et al. 2016. PLoS Pathog. 12:e1006032. PubMed
  148. Younes AI, et al. 2021. Transl Oncol. 14:100983. PubMed
  149. Zheng B, et al. 2021. Bioact Mater. 6:3879. PubMed
  150. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  151. Godwin MS, et al. 2021. Am J Physiol Lung Cell Mol Physiol. 320:L393. PubMed
  152. Gu H, et al. 2021. Elife. 10:. PubMed
  153. Chen C, et al. 2020. Cell Rep. 2136:30. PubMed
  154. Damgaard RB et al. 2016. Cell. 166(5):1215-1230 . PubMed
  155. Yuan C, et al. 2015. Biochem Biophys Res Commun. 464: 249-255. PubMed
  156. Bussey KA, et al. 2019. J Virol. 93. PubMed
  157. Kataru RP, et al. 2019. Cancer Immunol Res. 7:1345. PubMed
  158. Melgert B, et al. 2010. Am J Respir Cell Mol Biol. 42:595. PubMed
  159. Park C, et al. 2012. J Leukoc Biol. 91:739. PubMed
  160. Fujimura N, et al. 2016. Sci Rep. 5:11664. PubMed
  161. Manifold-Wheeler B, et al. 2016. J Immunol. 196: 328 - 335. PubMed
  162. Zhou H, et al. 2016. J Immunol. 197: 288 - 295. PubMed
  163. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  164. Lai JH, et al. 2021. iScience. 24(6):102498. PubMed
  165. Parodi B, et al. 2021. Front Immunol. 12:655212. PubMed
  166. Sharma M, et al. 2019. Immunometabolism. 1. PubMed
  167. Zukauskas A, et al. 2018. mSphere. 3:e00303. PubMed
  168. Hao L, et al. 2021. Br J Pharmacol. 178:4726. PubMed
  169. Tomita T, et al. 2021. Nat Commun. 12:3655. PubMed
  170. Siolas D, et al. 2021. Cell Reports. 36:109578. PubMed
  171. Iwai H, et al. 2015. Tuberculosis (Edinb). 95:246. PubMed
  172. Li A, et al. 2018. Cancer Lett. 431:54. PubMed
  173. Mino T, et al. 2019. Nucleic Acids Res. 47:8838. PubMed
  174. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  175. Jones GS, et al. 2020. mSphere. 5:. PubMed
  176. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  177. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  178. Wu L, et al. 2020. Cancer Immunol Res. 710:8. PubMed
  179. Tian T, et al. 2020. Cancer Immunol Res. 660:8. PubMed
  180. Mangal JL, et al. 2020. J Mater Chem B. 8:5195. PubMed
  181. Huanga J, et al. 2013. J Immunol Methods. 387:254. PubMed
  182. Vecchiola A, et al. 2020. Front Endocrinol (Lausanne). 11:223. PubMed
  183. Giles DA, et al. 2018. J Clin Invest. 128:5322. PubMed
  184. Yamamoto R, et al. 2019. J Immunol. 203:167. PubMed
  185. Omenetti S, et al. 2019. Immunity. 51:77. PubMed
  186. Chen S, et al. 2018. Nat Commun. 9:5298. PubMed
  187. Syed I et al. 2018. Cell metabolism. 27(2):419-427 . PubMed
  188. Li CY, et al. 2022. Int J Mol Sci. 23:. PubMed
  189. Li C, et al. 2022. Front Cell Dev Biol. 10:913824. PubMed
  190. Zhong J, et al. 2021. Commun Biol. 4:865. PubMed
  191. Chow AK, et al. 2021. Cellular and Molecular Gastroenterology and Hepatology. :. PubMed
  192. Chng S, et al. 2016. Sci Rep. 6: 23820. PubMed
  193. Hou X, et al. 2020. Cell Reports. 28(1):172-189.e7.. PubMed
  194. Lin C et al. 2019. Immunity. 50(1):137-151 . PubMed
  195. Xiong Y, et al. 2020. J Nanobiotechnology. 18:66. PubMed
  196. Liang J, et al. 2021. Cancer Manag Res. 13:6977. PubMed
  197. Alam A, et al. 2022. Cancer Cell. 40:153. PubMed
  198. Du Y, et al. 2022. J Exp Med. 219: . PubMed
  199. Yu C, et al. 2022. Invest Ophthalmol Vis Sci. 63:1. PubMed
  200. Marquardt RM, et al. 2022. Int J Mol Sci. 23: . PubMed
  201. Zhao Z, et al. 2022. Adv Sci (Weinh). 9:e2201293. PubMed
  202. Silva Pereira S, et al. 2022. Elife. 11: . PubMed
  203. Zhang Z, et al. 2022. Mol Nutr Food Res. 66:e2200300. PubMed
  204. Zhu J, et al. 2022. Nat Commun. 13:7466. PubMed
  205. Hao J, et al. 2022. Cell Rep. 41:111804. PubMed
  206. An HW, et al. 2022. Cell Rep. 41:111878. PubMed
  207. Guo R, et al. 2022. Cells. 12: . PubMed
  208. Kulkarni R, et al. 2023. Life Sci Alliance. 6: . PubMed
  209. Kodali S, et al. 2022. J Immunol. 208:1085. PubMed
  210. Friedman D, et al. 2022. J Immunol. 208:1845. PubMed
  211. Reticker-Flynn NE, et al. 2022. Cell. 185:1924. PubMed
  212. Gao T, et al. 2022. Cell Biochem Biophys. 80:579. PubMed
  213. Lin J, et al. 2022. Adv Sci (Weinh). 9:e2202633. PubMed
  214. Harapas CR, et al. 2022. Sci Immunol. 7:eabi4611. PubMed
  215. Boroumand P, et al. 2022. Elife. 11:. PubMed
  216. Ou W, et al. 2023. Nat Commun. 14:392. PubMed
  217. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  218. Wang Y, et al. 2023. EBioMedicine. 90:104480. PubMed
  219. Cheong LY, et al. 2023. Nat Commun. 14:1213. PubMed
  220. Yin C, et al. 2023. Sci Rep. 13:3903. PubMed
  221. Fu S, et al. 2023. Nat Commun. 14:2248. PubMed
  222. Kaltenbach L, et al. 2023. Nat Immunol. 24:915. PubMed
  223. Yu L, et al. 2023. Front Oncol. 13:1174713. PubMed
  224. Hsieh MS, et al. 2023. NPJ Vaccines. 8:82. PubMed
  225. Zhang AQ, et al. 2023. Nat Biomed Eng. . PubMed
  226. Tseng JC, et al. 2023. Int J Biol Sci. 19:2648. PubMed
  227. Lee T, et al. 2014. Mol Biol Cell. 25:583. PubMed
  228. Koyama M, et al. 2015. J Exp Med. 212: 1303 - 1321. PubMed
  229. Zhao Z, et al. 2021. Nat Commun. 12:4355. PubMed
  230. Grigsby SM, et al. 2021. Cancers (Basel). 13:. PubMed
  231. Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed
  232. Tseng K, et al. 2009. J Immunol. 182:4590. PubMed
  233. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  234. Lee S, et al. 2021. JCI Insight. 6:. PubMed
  235. Fan L, et al. 2021. Cancers (Basel). 13:. PubMed
  236. Zhang R, et al. 2021. Cell Mol Immunol. 18:1222. PubMed
  237. Du J, et al. 2020. Developmental Cell. 55(6):737-753.e7. PubMed
  238. Naito Y, et al. 2019. American Journal of Physiology-Renal Physiology. 318(1):F238-F247. PubMed
  239. Jackson A, et al. 2014. J Leukoc Biol. 92:609. PubMed
  240. Blecher-Gonen R, et al. 2019. Cell Syst. 8:109. PubMed
  241. Baptista AP et al. 2019. Immunity. 50(5):1188-1201 . PubMed
  242. Lee H, et al. 2020. Cell Metabolism. 31(4):822-836. PubMed
  243. Kunimura K, et al. 2020. Cell Reports. 29(9):2823-2834.e7.. PubMed
  244. Zhang J, et al. 2021. MedComm (Beijing). 2:256. PubMed
  245. Kang S, et al. 2009. Gastroenterology. 137:1391. PubMed
  246. Clark K, et al. 2015. J Autoimmun. Available online 21 August 2015. PubMed
  247. Wu R, et al. 2019. J Cell Mol Med. 24:1684. PubMed
  248. Schmidleithner L et al. 2019. Immunity. 50(5):1232-1248 . PubMed
  249. Shu T, et al. 2022. Eur Respir J. Online ahead of print. PubMed
  250. Cheong SS, et al. 2020. Front Cell Dev Biol. 8:577201. PubMed
  251. Li Q et al. 2018. Immunity. 48(2):258-270 . PubMed
  252. Nakagawa S et al. 2017. Cell host & microbe. 22(5):667-677 . PubMed
  253. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  254. Lees JG, et al. 2020. PLoS One. 15:e0238164. PubMed
  255. Xiong A, et al. 2022. EBioMedicine. 83:104239. PubMed
  256. Hu K, et al. 2015. PLoS One. 10: 0137123. PubMed
  257. Toivonen R, et al. 2016. J Immunol. 196: 4750 - 4759. PubMed
  258. Shemer A, et al. 2020. Immunity. 53(5):1033-1049.e7. PubMed
  259. Brooks JF, et al. 2020. Cytotherapy. 22:436. PubMed
  260. Privratsky JR, et al. 2018. Am J Physiol Renal Physiol. 315:F682. PubMed
  261. Akram KM, et al. 2019. Nat Commun. 10:1178. PubMed
  262. Tran L, et al. 2017. Cancer Immunol Res. 5:1141. PubMed
  263. Wang C, et al. 2017. J Immunol. 10.4049/jimmunol.1700671. PubMed
  264. Li X, et al. 2015. J Immunol. 195: 2710-2721. PubMed
  265. Fujita K, et al. 2019. Proc Natl Acad Sci U S A. 116:14714. PubMed
  266. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  267. Ramos CV, et al. 2020. Cell Reports. 32(3):107910. PubMed
  268. Dane EL, et al. 2022. Nat Mater. 21:710. PubMed
  269. Syed A, et al. 2015. Infect Immun . 83: 3428-3437. PubMed
  270. Ma Y, et al. 2015. J Immunol. 195: 3769 - 3780. PubMed
  271. Chi Z, et al. 2020. Molecular Cell. 80(1):43-58.e7. PubMed
  272. Fulham MA, et al. 2019. Am J Physiol Cell Physiol. 317:C687. PubMed
  273. Benechet AP, et al. 2019. Nature. 574:200. PubMed
  274. Feng T, et al. 2022. Nat Commun. 13:5208. PubMed
  275. Zhang L, et al. 2021. J Immunother Cancer. 9:. PubMed
  276. Li Z, et al. 2022. J Exp Clin Cancer Res. 41:74. PubMed
  277. Wu L, et al. 2022. Theranostics. 12:842. PubMed
  278. Jiao Y, et al. 2021. Crit Care. 25:356. PubMed
  279. Jeong SH, et al. 2021. Nat Commun. 12:4405. PubMed
  280. Carozza JA, et al. 2020. Nat Cancer. 184:1. PubMed
  281. Aegerter H, et al. 2020. Nat Immunol. 0.975694444. PubMed
  282. Galvani E, et al. 2020. Nat Commun. 11:853. PubMed
  283. Wang J, et al. 2021. Nat Commun. 12:6198. PubMed
  284. Friedman DJ, et al. 2021. Cancer Immunol Res. 9:952. PubMed
  285. Glaros V, et al. 2021. Immunity. 54:2005. PubMed
  286. Guo Y, et al. 2022. Nat Commun. 13:6534. PubMed
  287. Ray A, et al. 2015. PLoS One. 10: 0137314. PubMed
  288. Garcia LR, et al. 2021. Nat Commun. 12:3364. PubMed
  289. Park SG, et al. 2021. J Vet Sci. 22:e16. PubMed
  290. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  291. Garo LP, et al. 2019. Cell Rep. 28:3353. PubMed
  292. Miteva K, et al. 2018. Sci Rep. 8:2820. PubMed
  293. Ding Y, et al. 2022. Cell Death Dis. 13:996. PubMed
  294. Yong L, et al. 2022. Nat Commun. 13:4255. PubMed
  295. Pilones KA, et al. 2020. Cancer Immunol Res. 8:1054. PubMed
  296. Reinfeld BI, et al. 2021. Nature. 593:282. PubMed
  297. Toubal A, et al. 2020. Nat Commun. 3755:11. PubMed
  298. Barsoumian HB, et al. 2020. J Immunother Cancer. 8:00. PubMed
  299. Osaka M, et al. 2016. Sci Rep. 6:21391. PubMed
  300. Van Winkle JA et al. 2018. Cell host & microbe. 24(5):665-676 . PubMed
  301. LaFleur MW, et al. 2019. Nat Commun. 10:1668. PubMed
  302. Yang H, et al. 2019. J Neuroinflammation. 16:169. PubMed
  303. Liu S, et al. 2020. Cell Host & Microbe. 26(6):779-794.e8.. PubMed
  304. Vorselen D, et al. 2021. Elife. 10:. PubMed
  305. Dey S, et al. 2020. J Immunother Cancer. 8:. PubMed
  306. Olson M, et al. 2014. J Immunol. 193:5420. PubMed
  307. Zeng W, et al. 2021. STAR Protocols. 2(1):100361. PubMed
  308. De Simone G, et al. 2021. Immunity. :. PubMed
  309. Lim CX, et al. 2020. Cell Rep. 3793:30. PubMed
  310. Choi EW, et al. 2020. Sci Rep. 10:12001. PubMed
  311. López MJ, et al. 2018. Invest Ophthalmol Vis Sci. 59:5671. PubMed
  312. Cohen M et al. 2018. Cell. 175(4):1031-1044 . PubMed
  313. Maulloo CD, et al. 2021. Front Immunol. 12:714842. PubMed
  314. Koikawa K, et al. 2021. Cell. 184:4753. PubMed
  315. Hanihara-Tatsuzawa F, et al. 2014. J Biol Chem. 389:30925. PubMed
  316. Hsu Y, et al. 2017. Biochem Biophys Res Commun.. 10.1016/j.bbrc.2017.10.067. PubMed
  317. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  318. Lebel MÈ, et al. 2020. Nat Commun. 3.051388889. PubMed
  319. Benhamron S, et al. 2012. PLoS One. 7:e35602. PubMed
  320. Li D, et al. 2022. Emerg Microbes Infect. 11:2248. PubMed
  321. Hu Y, et al. 2021. Cell Death Dis. 12:743. PubMed
  322. Rosenbaum SR, et al. 2020. Cell Rep. 30:510. PubMed
  323. Yuan X, et al. 2017. Elife. 6:e29540. PubMed
  324. Wang Y, et al. 2021. Nat Commun. 12:4964. PubMed
  325. Takahashi F, et al. 2022. iScience. 25:104278. PubMed
  326. Wang W, et al. 2021. J Am Heart Assoc. 10:e019142. PubMed
  327. Nahrendorf W, et al. 2021. eLife. 10:00. PubMed
  328. Bi CS, et al. 2020. Cell Prolif. 53:e12827. PubMed
  329. Nechama M, et al. 2018. Nat Commun. 9:1603. PubMed
  330. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  331. Oliveira AC et al. 2017. eLife. 6 pii: e30883. PubMed
  332. Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed
  333. Lu X, et al. 2019. Circ Res. 125:1055. PubMed
  334. Zhang MS, et al. 2022. Nat Commun. 13:954. PubMed
  335. Tuong ZK, et al. 2021. Cell Rep. 37:110132. PubMed
  336. Kataru RP, et al. 2022. Front Aging. 3:864860. PubMed
  337. Al-Barwani F, et al. 2014. PLoS One. 9:104523. PubMed
  338. Holzki J, et al. 2015. J Virol. 89: 9886 - 9895. PubMed
  339. Gamradt P, et al. 2016. PLoS Pathog. 12:e1006032. PubMed
  340. Younes AI, et al. 2021. Transl Oncol. 14:100983. PubMed
  341. Zheng B, et al. 2021. Bioact Mater. 6:3879. PubMed
  342. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  343. Godwin MS, et al. 2021. Am J Physiol Lung Cell Mol Physiol. 320:L393. PubMed
  344. Gu H, et al. 2021. Elife. 10:. PubMed
  345. Chen C, et al. 2020. Cell Rep. 2136:30. PubMed
  346. Damgaard RB et al. 2016. Cell. 166(5):1215-1230 . PubMed
  347. Yuan C, et al. 2015. Biochem Biophys Res Commun. 464: 249-255. PubMed
  348. Bussey KA, et al. 2019. J Virol. 93. PubMed
  349. Kataru RP, et al. 2019. Cancer Immunol Res. 7:1345. PubMed
  350. Melgert B, et al. 2010. Am J Respir Cell Mol Biol. 42:595. PubMed
  351. Park C, et al. 2012. J Leukoc Biol. 91:739. PubMed
  352. Fujimura N, et al. 2016. Sci Rep. 5:11664. PubMed
  353. Manifold-Wheeler B, et al. 2016. J Immunol. 196: 328 - 335. PubMed
  354. Zhou H, et al. 2016. J Immunol. 197: 288 - 295. PubMed
  355. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  356. Lai JH, et al. 2021. iScience. 24(6):102498. PubMed
  357. Parodi B, et al. 2021. Front Immunol. 12:655212. PubMed
  358. Sharma M, et al. 2019. Immunometabolism. 1. PubMed
  359. Zukauskas A, et al. 2018. mSphere. 3:e00303. PubMed
  360. Hao L, et al. 2021. Br J Pharmacol. 178:4726. PubMed
  361. Tomita T, et al. 2021. Nat Commun. 12:3655. PubMed
  362. Siolas D, et al. 2021. Cell Reports. 36:109578. PubMed
  363. Iwai H, et al. 2015. Tuberculosis (Edinb). 95:246. PubMed
  364. Li A, et al. 2018. Cancer Lett. 431:54. PubMed
  365. Mino T, et al. 2019. Nucleic Acids Res. 47:8838. PubMed
  366. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  367. Jones GS, et al. 2020. mSphere. 5:. PubMed
  368. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  369. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  370. Wu L, et al. 2020. Cancer Immunol Res. 710:8. PubMed
  371. Tian T, et al. 2020. Cancer Immunol Res. 660:8. PubMed
  372. Mangal JL, et al. 2020. J Mater Chem B. 8:5195. PubMed
  373. Huanga J, et al. 2013. J Immunol Methods. 387:254. PubMed
  374. Vecchiola A, et al. 2020. Front Endocrinol (Lausanne). 11:223. PubMed
  375. Giles DA, et al. 2018. J Clin Invest. 128:5322. PubMed
  376. Yamamoto R, et al. 2019. J Immunol. 203:167. PubMed
  377. Omenetti S, et al. 2019. Immunity. 51:77. PubMed
  378. Chen S, et al. 2018. Nat Commun. 9:5298. PubMed
  379. Syed I et al. 2018. Cell metabolism. 27(2):419-427 . PubMed
  380. Li CY, et al. 2022. Int J Mol Sci. 23:. PubMed
  381. Li C, et al. 2022. Front Cell Dev Biol. 10:913824. PubMed
  382. Zhong J, et al. 2021. Commun Biol. 4:865. PubMed
  383. Chow AK, et al. 2021. Cellular and Molecular Gastroenterology and Hepatology. :. PubMed
  384. Chng S, et al. 2016. Sci Rep. 6: 23820. PubMed
RRID
AB_313777 (BioLegend Cat. No. 117308)
AB_313776 (BioLegend Cat. No. 117307)

Antigen Details

Structure
Integrin α-chain, associates with integrin β2 (CD18), 150 kD
Distribution

Dendritic cells, NK cells, intestinal intraepithelial lymphocytes (IEL), some activated T cells

Function
Cellular adhesion
Ligand/Receptor
iC3b, fibrinogen
Cell Type
Dendritic cells, Epithelial cells, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen Facts Book Academic Press.
2. Springer TA. 1994. Cell 76:301.
3. Lopez-Rodriguez C, et al. 1996. J. Immunol. 156:3780.

Gene ID
16411 View all products for this Gene ID
UniProt
View information about CD11c on UniProt.org

Related FAQs

What type of PE do you use in your conjugates?
We use R-PE in our conjugates.

Other Formats

View All CD11c Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse CD11c N418 FC
Biotin anti-mouse CD11c N418 FC,IHC-F
FITC anti-mouse CD11c N418 FC
PE anti-mouse CD11c N418 FC
Purified anti-mouse CD11c N418 FC,CyTOF®,IP,IHC
Brilliant Violet 711™ anti-mouse CD11c N418 FC
APC/Fire™ 750 anti-mouse CD11c N418 FC
TotalSeq™-A0106 anti-mouse CD11c N418 PG
Brilliant Violet 750™ anti-mouse CD11c N418 FC
TotalSeq™-B0106 anti-mouse CD11c N418 PG
TotalSeq™-C0106 anti-mouse CD11c N418 PG
KIRAVIA Blue 520™ anti-mouse CD11c N418 FC
Spark Blue™ 550 anti-mouse CD11c N418 FC
Alexa Fluor® 488 anti-mouse CD11c N418 FC
Alexa Fluor® 647 anti-mouse CD11c N418 FC,IHC,ICC,3D IHC
PE/Cyanine5 anti-mouse CD11c N418 FC
PE/Cyanine7 anti-mouse CD11c N418 FC
Brilliant Violet 605™ anti-mouse CD11c N418 FC
Alexa Fluor® 700 anti-mouse CD11c N418 FC
Pacific Blue™ anti-mouse CD11c N418 FC
APC/Cyanine7 anti-mouse CD11c N418 FC
PerCP/Cyanine5.5 anti-mouse CD11c N418 FC
PerCP anti-mouse CD11c N418 FC
Brilliant Violet 421™ anti-mouse CD11c N418 FC,IHC
Brilliant Violet 570™ anti-mouse CD11c N418 FC
Brilliant Violet 785™ anti-mouse CD11c N418 FC
Brilliant Violet 510™ anti-mouse CD11c N418 FC
Brilliant Violet 650™ anti-mouse CD11c N418 FC
Purified anti-mouse CD11c (Maxpar® Ready) N418 FC,CyTOF®
Alexa Fluor® 594 anti-mouse CD11c N418 IHC-F,3D IHC
PE/Dazzle™ 594 anti-mouse CD11c N418 FC
Spark NIR™ 685 anti-mouse CD11c N418 FC
Spark UV™ 387 anti-mouse CD11c N418 FC
Spark Red™ 718 anti-mouse CD11c N418 FC
Spark Blue™ 515 anti-mouse CD11c N418 FC
PerCP/Fire™ 806 anti-mouse CD11c N418 FC
Spark PLUS UV395™ anti-mouse CD11c N418 FC
Spark Blue™ 574 anti-mouse CD11c (Flexi-Fluor™) N418 FC
Spark PLUS B550™ anti-mouse CD11c N418 FC
APC/Fire™ 810 anti-mouse CD11c Antibody N418 FC
PE/Fire™ 640 anti-mouse CD11c Antibody N418 FC
Spark YG™ 581 anti-mouse CD11c (Flexi-Fluor™) N418 FC
Spark YG™ 593 anti-mouse CD11c (Flexi-Fluor™) Antibody N418 FC
Spark PLUS V475™ anti-mouse CD11c Antibody N418 FC
Go To Top Version: 1    Revision Date: 11-30-2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

Pricing & Availability
Clone
N418 (See other available formats)
Regulatory Status
RUO
Other Names
αX integrin, integrin αX chain, CR4, p150, ITGAX
Isotype
Armenian Hamster IgG
Ave. Rating
Submit a Review
Product Citations
publications
N418_A_PE_Pos_071006.jpg
C57BL/6 mouse splenocytes stained with APC anti-mouse I-A/I-E (clone M5/114.15.2) and PE N418 (top) or PE Armenian hamster IgG isotype control (bottom)
  • N418_A_PE_Pos_071006.jpg
    C57BL/6 mouse splenocytes stained with APC anti-mouse I-A/I-E (clone M5/114.15.2) and PE N418 (top) or PE Armenian hamster IgG isotype control (bottom)
  • N418_B_PE_Neg_071006.jpg
    C57BL/6 mouse splenocytes stained with APC anti-mouse I-A/I-E (clone M5/114.15.2) and PE N418 (top) or PE Armenian hamster IgG isotype control (bottom)
Compare all formats See PE spectral data
Cat # Size Price Quantity Check Availability Save
117308 200 µg SEK1538
Check Availability


Need larger quantities of this item?
Request Bulk Quote
117307 50 µg SEK605
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD11c is a 150 kD glycoprotein also known as αX integrin, CR4, and p150. CD11c forms a αXβ2 heterodimer with β2 integrin (CD18). It is primarily expressed on dendritic cells, NK cells, a subset of intestinal intraepithelial lymphocytes (IEL), and some activated T cells. The αXβ2 integrin plays an important role in cell-cell contact by binding its ligands: iC3b, fibrinogen, and CD54.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Armenian Hamster
Immunogen
Mouse spleen dendritic cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The CD11c antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for other applications.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Additional reported applications (for the relevant formats) include: immunoprecipitation3, immunohistochemical staining of acetone-fixed frozen sections3, immunofluorescence microscopy5, 9 (Alexa Fluor® 488 conjugated N418 was used for IHC in frozen sections10), and spatial biology (IBEX)22,23.

Application References
  1. Granucci F, et al. 1997. J. Immunol. 159:1794.
  2. Stokes RW, et al. 1998. J. Immunol. 160:5514.
  3. Metlay JP, et al. 1990. J. Exp. Med. 171:1753. (IHC, IP)
  4. Ma XT, et al. 2006. Cancer Research 66:1169.
  5. Chin RK, et al. 2006. J. Immunol. 177:290. (IF)
  6. Cervantes-Barragan L, et al. 2007. Blood 109:1131. (FC) PubMed
  7. Turnquist HR, et al. 2007. J. Immunol. 178:7018. (FC) PubMed
  8. Benson MJ, et al. 2007. J. Exp. Med. doi:10.1084/jem.20070719. (FC) PubMed
  9. You Y, et al. 2009. J. Immunol. 182:7343. (IF) PubMed
  10. Roland CL, et al. 2009. Mol. Cancer Res. 8:1761. (IHC, FC) PubMed
  11. Wikstrom M, et al.2006. J. Immunol. 177:913. PubMed
  12. Pericolini E, et al. 2008. J. Leukocyte Biol. 83:1286. PubMed
  13. Randall LM, et al. 2008. Infect. Immun.76:3312. PubMed
  14. Fahlen-Yrild L, et al. 2009. J. Immunol. 183:5032. PubMed
  15. Osterholzer JJ, et al. 2009. J. Immunol. 183:8044. PubMed
  16. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  17. Eisenach PA, et al. 2010. J Cell Sci. 123:4182. PubMed
  18. Leppin K, et al. 2014. Invest. Ophthalmol. Vis. Sci. 55:3603. PubMed
  19. Sakai F, et al. 2014. PLoS One. 9:105370. PubMed
  20. Gibbins JD, et al. 2014. Blood. 124:2953. PubMed
  21. White CE, et al. 2015. J Immunol. 194:697. PubMed
  22. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
  23. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  24. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Hou X, et al. 2020. Cell Reports. 28(1):172-189.e7.. PubMed
  2. Lin C et al. 2019. Immunity. 50(1):137-151 . PubMed
  3. Xiong Y, et al. 2020. J Nanobiotechnology. 18:66. PubMed
  4. Liang J, et al. 2021. Cancer Manag Res. 13:6977. PubMed
  5. Alam A, et al. 2022. Cancer Cell. 40:153. PubMed
  6. Du Y, et al. 2022. J Exp Med. 219: . PubMed
  7. Yu C, et al. 2022. Invest Ophthalmol Vis Sci. 63:1. PubMed
  8. Marquardt RM, et al. 2022. Int J Mol Sci. 23: . PubMed
  9. Zhao Z, et al. 2022. Adv Sci (Weinh). 9:e2201293. PubMed
  10. Silva Pereira S, et al. 2022. Elife. 11: . PubMed
  11. Zhang Z, et al. 2022. Mol Nutr Food Res. 66:e2200300. PubMed
  12. Zhu J, et al. 2022. Nat Commun. 13:7466. PubMed
  13. Hao J, et al. 2022. Cell Rep. 41:111804. PubMed
  14. An HW, et al. 2022. Cell Rep. 41:111878. PubMed
  15. Guo R, et al. 2022. Cells. 12: . PubMed
  16. Kulkarni R, et al. 2023. Life Sci Alliance. 6: . PubMed
  17. Kodali S, et al. 2022. J Immunol. 208:1085. PubMed
  18. Friedman D, et al. 2022. J Immunol. 208:1845. PubMed
  19. Reticker-Flynn NE, et al. 2022. Cell. 185:1924. PubMed
  20. Gao T, et al. 2022. Cell Biochem Biophys. 80:579. PubMed
  21. Lin J, et al. 2022. Adv Sci (Weinh). 9:e2202633. PubMed
  22. Harapas CR, et al. 2022. Sci Immunol. 7:eabi4611. PubMed
  23. Boroumand P, et al. 2022. Elife. 11:. PubMed
  24. Ou W, et al. 2023. Nat Commun. 14:392. PubMed
  25. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  26. Wang Y, et al. 2023. EBioMedicine. 90:104480. PubMed
  27. Cheong LY, et al. 2023. Nat Commun. 14:1213. PubMed
  28. Yin C, et al. 2023. Sci Rep. 13:3903. PubMed
  29. Fu S, et al. 2023. Nat Commun. 14:2248. PubMed
  30. Kaltenbach L, et al. 2023. Nat Immunol. 24:915. PubMed
  31. Yu L, et al. 2023. Front Oncol. 13:1174713. PubMed
  32. Hsieh MS, et al. 2023. NPJ Vaccines. 8:82. PubMed
  33. Zhang AQ, et al. 2023. Nat Biomed Eng. . PubMed
  34. Tseng JC, et al. 2023. Int J Biol Sci. 19:2648. PubMed
  35. Lee T, et al. 2014. Mol Biol Cell. 25:583. PubMed
  36. Koyama M, et al. 2015. J Exp Med. 212: 1303 - 1321. PubMed
  37. Zhao Z, et al. 2021. Nat Commun. 12:4355. PubMed
  38. Grigsby SM, et al. 2021. Cancers (Basel). 13:. PubMed
  39. Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed
  40. Tseng K, et al. 2009. J Immunol. 182:4590. PubMed
  41. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  42. Lee S, et al. 2021. JCI Insight. 6:. PubMed
  43. Fan L, et al. 2021. Cancers (Basel). 13:. PubMed
  44. Zhang R, et al. 2021. Cell Mol Immunol. 18:1222. PubMed
  45. Du J, et al. 2020. Developmental Cell. 55(6):737-753.e7. PubMed
  46. Naito Y, et al. 2019. American Journal of Physiology-Renal Physiology. 318(1):F238-F247. PubMed
  47. Jackson A, et al. 2014. J Leukoc Biol. 92:609. PubMed
  48. Blecher-Gonen R, et al. 2019. Cell Syst. 8:109. PubMed
  49. Baptista AP et al. 2019. Immunity. 50(5):1188-1201 . PubMed
  50. Lee H, et al. 2020. Cell Metabolism. 31(4):822-836. PubMed
  51. Kunimura K, et al. 2020. Cell Reports. 29(9):2823-2834.e7.. PubMed
  52. Zhang J, et al. 2021. MedComm (Beijing). 2:256. PubMed
  53. Kang S, et al. 2009. Gastroenterology. 137:1391. PubMed
  54. Clark K, et al. 2015. J Autoimmun. Available online 21 August 2015. PubMed
  55. Wu R, et al. 2019. J Cell Mol Med. 24:1684. PubMed
  56. Schmidleithner L et al. 2019. Immunity. 50(5):1232-1248 . PubMed
  57. Shu T, et al. 2022. Eur Respir J. Online ahead of print. PubMed
  58. Cheong SS, et al. 2020. Front Cell Dev Biol. 8:577201. PubMed
  59. Li Q et al. 2018. Immunity. 48(2):258-270 . PubMed
  60. Nakagawa S et al. 2017. Cell host & microbe. 22(5):667-677 . PubMed
  61. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  62. Lees JG, et al. 2020. PLoS One. 15:e0238164. PubMed
  63. Xiong A, et al. 2022. EBioMedicine. 83:104239. PubMed
  64. Hu K, et al. 2015. PLoS One. 10: 0137123. PubMed
  65. Toivonen R, et al. 2016. J Immunol. 196: 4750 - 4759. PubMed
  66. Shemer A, et al. 2020. Immunity. 53(5):1033-1049.e7. PubMed
  67. Brooks JF, et al. 2020. Cytotherapy. 22:436. PubMed
  68. Privratsky JR, et al. 2018. Am J Physiol Renal Physiol. 315:F682. PubMed
  69. Akram KM, et al. 2019. Nat Commun. 10:1178. PubMed
  70. Tran L, et al. 2017. Cancer Immunol Res. 5:1141. PubMed
  71. Wang C, et al. 2017. J Immunol. 10.4049/jimmunol.1700671. PubMed
  72. Li X, et al. 2015. J Immunol. 195: 2710-2721. PubMed
  73. Fujita K, et al. 2019. Proc Natl Acad Sci U S A. 116:14714. PubMed
  74. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  75. Ramos CV, et al. 2020. Cell Reports. 32(3):107910. PubMed
  76. Dane EL, et al. 2022. Nat Mater. 21:710. PubMed
  77. Syed A, et al. 2015. Infect Immun . 83: 3428-3437. PubMed
  78. Ma Y, et al. 2015. J Immunol. 195: 3769 - 3780. PubMed
  79. Chi Z, et al. 2020. Molecular Cell. 80(1):43-58.e7. PubMed
  80. Fulham MA, et al. 2019. Am J Physiol Cell Physiol. 317:C687. PubMed
  81. Benechet AP, et al. 2019. Nature. 574:200. PubMed
  82. Feng T, et al. 2022. Nat Commun. 13:5208. PubMed
  83. Zhang L, et al. 2021. J Immunother Cancer. 9:. PubMed
  84. Li Z, et al. 2022. J Exp Clin Cancer Res. 41:74. PubMed
  85. Wu L, et al. 2022. Theranostics. 12:842. PubMed
  86. Jiao Y, et al. 2021. Crit Care. 25:356. PubMed
  87. Jeong SH, et al. 2021. Nat Commun. 12:4405. PubMed
  88. Carozza JA, et al. 2020. Nat Cancer. 184:1. PubMed
  89. Aegerter H, et al. 2020. Nat Immunol. 0.975694444. PubMed
  90. Galvani E, et al. 2020. Nat Commun. 11:853. PubMed
  91. Wang J, et al. 2021. Nat Commun. 12:6198. PubMed
  92. Friedman DJ, et al. 2021. Cancer Immunol Res. 9:952. PubMed
  93. Glaros V, et al. 2021. Immunity. 54:2005. PubMed
  94. Guo Y, et al. 2022. Nat Commun. 13:6534. PubMed
  95. Ray A, et al. 2015. PLoS One. 10: 0137314. PubMed
  96. Garcia LR, et al. 2021. Nat Commun. 12:3364. PubMed
  97. Park SG, et al. 2021. J Vet Sci. 22:e16. PubMed
  98. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  99. Garo LP, et al. 2019. Cell Rep. 28:3353. PubMed
  100. Miteva K, et al. 2018. Sci Rep. 8:2820. PubMed
  101. Ding Y, et al. 2022. Cell Death Dis. 13:996. PubMed
  102. Yong L, et al. 2022. Nat Commun. 13:4255. PubMed
  103. Pilones KA, et al. 2020. Cancer Immunol Res. 8:1054. PubMed
  104. Reinfeld BI, et al. 2021. Nature. 593:282. PubMed
  105. Toubal A, et al. 2020. Nat Commun. 3755:11. PubMed
  106. Barsoumian HB, et al. 2020. J Immunother Cancer. 8:00. PubMed
  107. Osaka M, et al. 2016. Sci Rep. 6:21391. PubMed
  108. Van Winkle JA et al. 2018. Cell host & microbe. 24(5):665-676 . PubMed
  109. LaFleur MW, et al. 2019. Nat Commun. 10:1668. PubMed
  110. Yang H, et al. 2019. J Neuroinflammation. 16:169. PubMed
  111. Liu S, et al. 2020. Cell Host & Microbe. 26(6):779-794.e8.. PubMed
  112. Vorselen D, et al. 2021. Elife. 10:. PubMed
  113. Dey S, et al. 2020. J Immunother Cancer. 8:. PubMed
  114. Olson M, et al. 2014. J Immunol. 193:5420. PubMed
  115. Zeng W, et al. 2021. STAR Protocols. 2(1):100361. PubMed
  116. De Simone G, et al. 2021. Immunity. :. PubMed
  117. Lim CX, et al. 2020. Cell Rep. 3793:30. PubMed
  118. Choi EW, et al. 2020. Sci Rep. 10:12001. PubMed
  119. López MJ, et al. 2018. Invest Ophthalmol Vis Sci. 59:5671. PubMed
  120. Cohen M et al. 2018. Cell. 175(4):1031-1044 . PubMed
  121. Maulloo CD, et al. 2021. Front Immunol. 12:714842. PubMed
  122. Koikawa K, et al. 2021. Cell. 184:4753. PubMed
  123. Hanihara-Tatsuzawa F, et al. 2014. J Biol Chem. 389:30925. PubMed
  124. Hsu Y, et al. 2017. Biochem Biophys Res Commun.. 10.1016/j.bbrc.2017.10.067. PubMed
  125. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  126. Lebel MÈ, et al. 2020. Nat Commun. 3.051388889. PubMed
  127. Benhamron S, et al. 2012. PLoS One. 7:e35602. PubMed
  128. Li D, et al. 2022. Emerg Microbes Infect. 11:2248. PubMed
  129. Hu Y, et al. 2021. Cell Death Dis. 12:743. PubMed
  130. Rosenbaum SR, et al. 2020. Cell Rep. 30:510. PubMed
  131. Yuan X, et al. 2017. Elife. 6:e29540. PubMed
  132. Wang Y, et al. 2021. Nat Commun. 12:4964. PubMed
  133. Takahashi F, et al. 2022. iScience. 25:104278. PubMed
  134. Wang W, et al. 2021. J Am Heart Assoc. 10:e019142. PubMed
  135. Nahrendorf W, et al. 2021. eLife. 10:00. PubMed
  136. Bi CS, et al. 2020. Cell Prolif. 53:e12827. PubMed
  137. Nechama M, et al. 2018. Nat Commun. 9:1603. PubMed
  138. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  139. Oliveira AC et al. 2017. eLife. 6 pii: e30883. PubMed
  140. Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed
  141. Lu X, et al. 2019. Circ Res. 125:1055. PubMed
  142. Zhang MS, et al. 2022. Nat Commun. 13:954. PubMed
  143. Tuong ZK, et al. 2021. Cell Rep. 37:110132. PubMed
  144. Kataru RP, et al. 2022. Front Aging. 3:864860. PubMed
  145. Al-Barwani F, et al. 2014. PLoS One. 9:104523. PubMed
  146. Holzki J, et al. 2015. J Virol. 89: 9886 - 9895. PubMed
  147. Gamradt P, et al. 2016. PLoS Pathog. 12:e1006032. PubMed
  148. Younes AI, et al. 2021. Transl Oncol. 14:100983. PubMed
  149. Zheng B, et al. 2021. Bioact Mater. 6:3879. PubMed
  150. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  151. Godwin MS, et al. 2021. Am J Physiol Lung Cell Mol Physiol. 320:L393. PubMed
  152. Gu H, et al. 2021. Elife. 10:. PubMed
  153. Chen C, et al. 2020. Cell Rep. 2136:30. PubMed
  154. Damgaard RB et al. 2016. Cell. 166(5):1215-1230 . PubMed
  155. Yuan C, et al. 2015. Biochem Biophys Res Commun. 464: 249-255. PubMed
  156. Bussey KA, et al. 2019. J Virol. 93. PubMed
  157. Kataru RP, et al. 2019. Cancer Immunol Res. 7:1345. PubMed
  158. Melgert B, et al. 2010. Am J Respir Cell Mol Biol. 42:595. PubMed
  159. Park C, et al. 2012. J Leukoc Biol. 91:739. PubMed
  160. Fujimura N, et al. 2016. Sci Rep. 5:11664. PubMed
  161. Manifold-Wheeler B, et al. 2016. J Immunol. 196: 328 - 335. PubMed
  162. Zhou H, et al. 2016. J Immunol. 197: 288 - 295. PubMed
  163. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  164. Lai JH, et al. 2021. iScience. 24(6):102498. PubMed
  165. Parodi B, et al. 2021. Front Immunol. 12:655212. PubMed
  166. Sharma M, et al. 2019. Immunometabolism. 1. PubMed
  167. Zukauskas A, et al. 2018. mSphere. 3:e00303. PubMed
  168. Hao L, et al. 2021. Br J Pharmacol. 178:4726. PubMed
  169. Tomita T, et al. 2021. Nat Commun. 12:3655. PubMed
  170. Siolas D, et al. 2021. Cell Reports. 36:109578. PubMed
  171. Iwai H, et al. 2015. Tuberculosis (Edinb). 95:246. PubMed
  172. Li A, et al. 2018. Cancer Lett. 431:54. PubMed
  173. Mino T, et al. 2019. Nucleic Acids Res. 47:8838. PubMed
  174. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  175. Jones GS, et al. 2020. mSphere. 5:. PubMed
  176. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  177. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  178. Wu L, et al. 2020. Cancer Immunol Res. 710:8. PubMed
  179. Tian T, et al. 2020. Cancer Immunol Res. 660:8. PubMed
  180. Mangal JL, et al. 2020. J Mater Chem B. 8:5195. PubMed
  181. Huanga J, et al. 2013. J Immunol Methods. 387:254. PubMed
  182. Vecchiola A, et al. 2020. Front Endocrinol (Lausanne). 11:223. PubMed
  183. Giles DA, et al. 2018. J Clin Invest. 128:5322. PubMed
  184. Yamamoto R, et al. 2019. J Immunol. 203:167. PubMed
  185. Omenetti S, et al. 2019. Immunity. 51:77. PubMed
  186. Chen S, et al. 2018. Nat Commun. 9:5298. PubMed
  187. Syed I et al. 2018. Cell metabolism. 27(2):419-427 . PubMed
  188. Li CY, et al. 2022. Int J Mol Sci. 23:. PubMed
  189. Li C, et al. 2022. Front Cell Dev Biol. 10:913824. PubMed
  190. Zhong J, et al. 2021. Commun Biol. 4:865. PubMed
  191. Chow AK, et al. 2021. Cellular and Molecular Gastroenterology and Hepatology. :. PubMed
  192. Chng S, et al. 2016. Sci Rep. 6: 23820. PubMed
  193. Hou X, et al. 2020. Cell Reports. 28(1):172-189.e7.. PubMed
  194. Lin C et al. 2019. Immunity. 50(1):137-151 . PubMed
  195. Xiong Y, et al. 2020. J Nanobiotechnology. 18:66. PubMed
  196. Liang J, et al. 2021. Cancer Manag Res. 13:6977. PubMed
  197. Alam A, et al. 2022. Cancer Cell. 40:153. PubMed
  198. Du Y, et al. 2022. J Exp Med. 219: . PubMed
  199. Yu C, et al. 2022. Invest Ophthalmol Vis Sci. 63:1. PubMed
  200. Marquardt RM, et al. 2022. Int J Mol Sci. 23: . PubMed
  201. Zhao Z, et al. 2022. Adv Sci (Weinh). 9:e2201293. PubMed
  202. Silva Pereira S, et al. 2022. Elife. 11: . PubMed
  203. Zhang Z, et al. 2022. Mol Nutr Food Res. 66:e2200300. PubMed
  204. Zhu J, et al. 2022. Nat Commun. 13:7466. PubMed
  205. Hao J, et al. 2022. Cell Rep. 41:111804. PubMed
  206. An HW, et al. 2022. Cell Rep. 41:111878. PubMed
  207. Guo R, et al. 2022. Cells. 12: . PubMed
  208. Kulkarni R, et al. 2023. Life Sci Alliance. 6: . PubMed
  209. Kodali S, et al. 2022. J Immunol. 208:1085. PubMed
  210. Friedman D, et al. 2022. J Immunol. 208:1845. PubMed
  211. Reticker-Flynn NE, et al. 2022. Cell. 185:1924. PubMed
  212. Gao T, et al. 2022. Cell Biochem Biophys. 80:579. PubMed
  213. Lin J, et al. 2022. Adv Sci (Weinh). 9:e2202633. PubMed
  214. Harapas CR, et al. 2022. Sci Immunol. 7:eabi4611. PubMed
  215. Boroumand P, et al. 2022. Elife. 11:. PubMed
  216. Ou W, et al. 2023. Nat Commun. 14:392. PubMed
  217. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  218. Wang Y, et al. 2023. EBioMedicine. 90:104480. PubMed
  219. Cheong LY, et al. 2023. Nat Commun. 14:1213. PubMed
  220. Yin C, et al. 2023. Sci Rep. 13:3903. PubMed
  221. Fu S, et al. 2023. Nat Commun. 14:2248. PubMed
  222. Kaltenbach L, et al. 2023. Nat Immunol. 24:915. PubMed
  223. Yu L, et al. 2023. Front Oncol. 13:1174713. PubMed
  224. Hsieh MS, et al. 2023. NPJ Vaccines. 8:82. PubMed
  225. Zhang AQ, et al. 2023. Nat Biomed Eng. . PubMed
  226. Tseng JC, et al. 2023. Int J Biol Sci. 19:2648. PubMed
  227. Lee T, et al. 2014. Mol Biol Cell. 25:583. PubMed
  228. Koyama M, et al. 2015. J Exp Med. 212: 1303 - 1321. PubMed
  229. Zhao Z, et al. 2021. Nat Commun. 12:4355. PubMed
  230. Grigsby SM, et al. 2021. Cancers (Basel). 13:. PubMed
  231. Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed
  232. Tseng K, et al. 2009. J Immunol. 182:4590. PubMed
  233. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  234. Lee S, et al. 2021. JCI Insight. 6:. PubMed
  235. Fan L, et al. 2021. Cancers (Basel). 13:. PubMed
  236. Zhang R, et al. 2021. Cell Mol Immunol. 18:1222. PubMed
  237. Du J, et al. 2020. Developmental Cell. 55(6):737-753.e7. PubMed
  238. Naito Y, et al. 2019. American Journal of Physiology-Renal Physiology. 318(1):F238-F247. PubMed
  239. Jackson A, et al. 2014. J Leukoc Biol. 92:609. PubMed
  240. Blecher-Gonen R, et al. 2019. Cell Syst. 8:109. PubMed
  241. Baptista AP et al. 2019. Immunity. 50(5):1188-1201 . PubMed
  242. Lee H, et al. 2020. Cell Metabolism. 31(4):822-836. PubMed
  243. Kunimura K, et al. 2020. Cell Reports. 29(9):2823-2834.e7.. PubMed
  244. Zhang J, et al. 2021. MedComm (Beijing). 2:256. PubMed
  245. Kang S, et al. 2009. Gastroenterology. 137:1391. PubMed
  246. Clark K, et al. 2015. J Autoimmun. Available online 21 August 2015. PubMed
  247. Wu R, et al. 2019. J Cell Mol Med. 24:1684. PubMed
  248. Schmidleithner L et al. 2019. Immunity. 50(5):1232-1248 . PubMed
  249. Shu T, et al. 2022. Eur Respir J. Online ahead of print. PubMed
  250. Cheong SS, et al. 2020. Front Cell Dev Biol. 8:577201. PubMed
  251. Li Q et al. 2018. Immunity. 48(2):258-270 . PubMed
  252. Nakagawa S et al. 2017. Cell host & microbe. 22(5):667-677 . PubMed
  253. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  254. Lees JG, et al. 2020. PLoS One. 15:e0238164. PubMed
  255. Xiong A, et al. 2022. EBioMedicine. 83:104239. PubMed
  256. Hu K, et al. 2015. PLoS One. 10: 0137123. PubMed
  257. Toivonen R, et al. 2016. J Immunol. 196: 4750 - 4759. PubMed
  258. Shemer A, et al. 2020. Immunity. 53(5):1033-1049.e7. PubMed
  259. Brooks JF, et al. 2020. Cytotherapy. 22:436. PubMed
  260. Privratsky JR, et al. 2018. Am J Physiol Renal Physiol. 315:F682. PubMed
  261. Akram KM, et al. 2019. Nat Commun. 10:1178. PubMed
  262. Tran L, et al. 2017. Cancer Immunol Res. 5:1141. PubMed
  263. Wang C, et al. 2017. J Immunol. 10.4049/jimmunol.1700671. PubMed
  264. Li X, et al. 2015. J Immunol. 195: 2710-2721. PubMed
  265. Fujita K, et al. 2019. Proc Natl Acad Sci U S A. 116:14714. PubMed
  266. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  267. Ramos CV, et al. 2020. Cell Reports. 32(3):107910. PubMed
  268. Dane EL, et al. 2022. Nat Mater. 21:710. PubMed
  269. Syed A, et al. 2015. Infect Immun . 83: 3428-3437. PubMed
  270. Ma Y, et al. 2015. J Immunol. 195: 3769 - 3780. PubMed
  271. Chi Z, et al. 2020. Molecular Cell. 80(1):43-58.e7. PubMed
  272. Fulham MA, et al. 2019. Am J Physiol Cell Physiol. 317:C687. PubMed
  273. Benechet AP, et al. 2019. Nature. 574:200. PubMed
  274. Feng T, et al. 2022. Nat Commun. 13:5208. PubMed
  275. Zhang L, et al. 2021. J Immunother Cancer. 9:. PubMed
  276. Li Z, et al. 2022. J Exp Clin Cancer Res. 41:74. PubMed
  277. Wu L, et al. 2022. Theranostics. 12:842. PubMed
  278. Jiao Y, et al. 2021. Crit Care. 25:356. PubMed
  279. Jeong SH, et al. 2021. Nat Commun. 12:4405. PubMed
  280. Carozza JA, et al. 2020. Nat Cancer. 184:1. PubMed
  281. Aegerter H, et al. 2020. Nat Immunol. 0.975694444. PubMed
  282. Galvani E, et al. 2020. Nat Commun. 11:853. PubMed
  283. Wang J, et al. 2021. Nat Commun. 12:6198. PubMed
  284. Friedman DJ, et al. 2021. Cancer Immunol Res. 9:952. PubMed
  285. Glaros V, et al. 2021. Immunity. 54:2005. PubMed
  286. Guo Y, et al. 2022. Nat Commun. 13:6534. PubMed
  287. Ray A, et al. 2015. PLoS One. 10: 0137314. PubMed
  288. Garcia LR, et al. 2021. Nat Commun. 12:3364. PubMed
  289. Park SG, et al. 2021. J Vet Sci. 22:e16. PubMed
  290. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  291. Garo LP, et al. 2019. Cell Rep. 28:3353. PubMed
  292. Miteva K, et al. 2018. Sci Rep. 8:2820. PubMed
  293. Ding Y, et al. 2022. Cell Death Dis. 13:996. PubMed
  294. Yong L, et al. 2022. Nat Commun. 13:4255. PubMed
  295. Pilones KA, et al. 2020. Cancer Immunol Res. 8:1054. PubMed
  296. Reinfeld BI, et al. 2021. Nature. 593:282. PubMed
  297. Toubal A, et al. 2020. Nat Commun. 3755:11. PubMed
  298. Barsoumian HB, et al. 2020. J Immunother Cancer. 8:00. PubMed
  299. Osaka M, et al. 2016. Sci Rep. 6:21391. PubMed
  300. Van Winkle JA et al. 2018. Cell host & microbe. 24(5):665-676 . PubMed
  301. LaFleur MW, et al. 2019. Nat Commun. 10:1668. PubMed
  302. Yang H, et al. 2019. J Neuroinflammation. 16:169. PubMed
  303. Liu S, et al. 2020. Cell Host & Microbe. 26(6):779-794.e8.. PubMed
  304. Vorselen D, et al. 2021. Elife. 10:. PubMed
  305. Dey S, et al. 2020. J Immunother Cancer. 8:. PubMed
  306. Olson M, et al. 2014. J Immunol. 193:5420. PubMed
  307. Zeng W, et al. 2021. STAR Protocols. 2(1):100361. PubMed
  308. De Simone G, et al. 2021. Immunity. :. PubMed
  309. Lim CX, et al. 2020. Cell Rep. 3793:30. PubMed
  310. Choi EW, et al. 2020. Sci Rep. 10:12001. PubMed
  311. López MJ, et al. 2018. Invest Ophthalmol Vis Sci. 59:5671. PubMed
  312. Cohen M et al. 2018. Cell. 175(4):1031-1044 . PubMed
  313. Maulloo CD, et al. 2021. Front Immunol. 12:714842. PubMed
  314. Koikawa K, et al. 2021. Cell. 184:4753. PubMed
  315. Hanihara-Tatsuzawa F, et al. 2014. J Biol Chem. 389:30925. PubMed
  316. Hsu Y, et al. 2017. Biochem Biophys Res Commun.. 10.1016/j.bbrc.2017.10.067. PubMed
  317. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  318. Lebel MÈ, et al. 2020. Nat Commun. 3.051388889. PubMed
  319. Benhamron S, et al. 2012. PLoS One. 7:e35602. PubMed
  320. Li D, et al. 2022. Emerg Microbes Infect. 11:2248. PubMed
  321. Hu Y, et al. 2021. Cell Death Dis. 12:743. PubMed
  322. Rosenbaum SR, et al. 2020. Cell Rep. 30:510. PubMed
  323. Yuan X, et al. 2017. Elife. 6:e29540. PubMed
  324. Wang Y, et al. 2021. Nat Commun. 12:4964. PubMed
  325. Takahashi F, et al. 2022. iScience. 25:104278. PubMed
  326. Wang W, et al. 2021. J Am Heart Assoc. 10:e019142. PubMed
  327. Nahrendorf W, et al. 2021. eLife. 10:00. PubMed
  328. Bi CS, et al. 2020. Cell Prolif. 53:e12827. PubMed
  329. Nechama M, et al. 2018. Nat Commun. 9:1603. PubMed
  330. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  331. Oliveira AC et al. 2017. eLife. 6 pii: e30883. PubMed
  332. Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed
  333. Lu X, et al. 2019. Circ Res. 125:1055. PubMed
  334. Zhang MS, et al. 2022. Nat Commun. 13:954. PubMed
  335. Tuong ZK, et al. 2021. Cell Rep. 37:110132. PubMed
  336. Kataru RP, et al. 2022. Front Aging. 3:864860. PubMed
  337. Al-Barwani F, et al. 2014. PLoS One. 9:104523. PubMed
  338. Holzki J, et al. 2015. J Virol. 89: 9886 - 9895. PubMed
  339. Gamradt P, et al. 2016. PLoS Pathog. 12:e1006032. PubMed
  340. Younes AI, et al. 2021. Transl Oncol. 14:100983. PubMed
  341. Zheng B, et al. 2021. Bioact Mater. 6:3879. PubMed
  342. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  343. Godwin MS, et al. 2021. Am J Physiol Lung Cell Mol Physiol. 320:L393. PubMed
  344. Gu H, et al. 2021. Elife. 10:. PubMed
  345. Chen C, et al. 2020. Cell Rep. 2136:30. PubMed
  346. Damgaard RB et al. 2016. Cell. 166(5):1215-1230 . PubMed
  347. Yuan C, et al. 2015. Biochem Biophys Res Commun. 464: 249-255. PubMed
  348. Bussey KA, et al. 2019. J Virol. 93. PubMed
  349. Kataru RP, et al. 2019. Cancer Immunol Res. 7:1345. PubMed
  350. Melgert B, et al. 2010. Am J Respir Cell Mol Biol. 42:595. PubMed
  351. Park C, et al. 2012. J Leukoc Biol. 91:739. PubMed
  352. Fujimura N, et al. 2016. Sci Rep. 5:11664. PubMed
  353. Manifold-Wheeler B, et al. 2016. J Immunol. 196: 328 - 335. PubMed
  354. Zhou H, et al. 2016. J Immunol. 197: 288 - 295. PubMed
  355. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  356. Lai JH, et al. 2021. iScience. 24(6):102498. PubMed
  357. Parodi B, et al. 2021. Front Immunol. 12:655212. PubMed
  358. Sharma M, et al. 2019. Immunometabolism. 1. PubMed
  359. Zukauskas A, et al. 2018. mSphere. 3:e00303. PubMed
  360. Hao L, et al. 2021. Br J Pharmacol. 178:4726. PubMed
  361. Tomita T, et al. 2021. Nat Commun. 12:3655. PubMed
  362. Siolas D, et al. 2021. Cell Reports. 36:109578. PubMed
  363. Iwai H, et al. 2015. Tuberculosis (Edinb). 95:246. PubMed
  364. Li A, et al. 2018. Cancer Lett. 431:54. PubMed
  365. Mino T, et al. 2019. Nucleic Acids Res. 47:8838. PubMed
  366. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  367. Jones GS, et al. 2020. mSphere. 5:. PubMed
  368. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  369. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  370. Wu L, et al. 2020. Cancer Immunol Res. 710:8. PubMed
  371. Tian T, et al. 2020. Cancer Immunol Res. 660:8. PubMed
  372. Mangal JL, et al. 2020. J Mater Chem B. 8:5195. PubMed
  373. Huanga J, et al. 2013. J Immunol Methods. 387:254. PubMed
  374. Vecchiola A, et al. 2020. Front Endocrinol (Lausanne). 11:223. PubMed
  375. Giles DA, et al. 2018. J Clin Invest. 128:5322. PubMed
  376. Yamamoto R, et al. 2019. J Immunol. 203:167. PubMed
  377. Omenetti S, et al. 2019. Immunity. 51:77. PubMed
  378. Chen S, et al. 2018. Nat Commun. 9:5298. PubMed
  379. Syed I et al. 2018. Cell metabolism. 27(2):419-427 . PubMed
  380. Li CY, et al. 2022. Int J Mol Sci. 23:. PubMed
  381. Li C, et al. 2022. Front Cell Dev Biol. 10:913824. PubMed
  382. Zhong J, et al. 2021. Commun Biol. 4:865. PubMed
  383. Chow AK, et al. 2021. Cellular and Molecular Gastroenterology and Hepatology. :. PubMed
  384. Chng S, et al. 2016. Sci Rep. 6: 23820. PubMed
RRID
AB_313777 (BioLegend Cat. No. 117308)
AB_313776 (BioLegend Cat. No. 117307)

Antigen Details

Structure
Integrin α-chain, associates with integrin β2 (CD18), 150 kD
Distribution

Dendritic cells, NK cells, intestinal intraepithelial lymphocytes (IEL), some activated T cells

Function
Cellular adhesion
Ligand/Receptor
iC3b, fibrinogen
Cell Type
Dendritic cells, Epithelial cells, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen Facts Book Academic Press.
2. Springer TA. 1994. Cell 76:301.
3. Lopez-Rodriguez C, et al. 1996. J. Immunol. 156:3780.

Gene ID
16411 View all products for this Gene ID
UniProt
View information about CD11c on UniProt.org

Related FAQs

What type of PE do you use in your conjugates?
We use R-PE in our conjugates.

Other Formats

View All CD11c Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse CD11c N418 FC
Biotin anti-mouse CD11c N418 FC,IHC-F
FITC anti-mouse CD11c N418 FC
PE anti-mouse CD11c N418 FC
Purified anti-mouse CD11c N418 FC,CyTOF®,IP,IHC
Brilliant Violet 711™ anti-mouse CD11c N418 FC
APC/Fire™ 750 anti-mouse CD11c N418 FC
TotalSeq™-A0106 anti-mouse CD11c N418 PG
Brilliant Violet 750™ anti-mouse CD11c N418 FC
TotalSeq™-B0106 anti-mouse CD11c N418 PG
TotalSeq™-C0106 anti-mouse CD11c N418 PG
KIRAVIA Blue 520™ anti-mouse CD11c N418 FC
Spark Blue™ 550 anti-mouse CD11c N418 FC
Alexa Fluor® 488 anti-mouse CD11c N418 FC
Alexa Fluor® 647 anti-mouse CD11c N418 FC,IHC,ICC,3D IHC
PE/Cyanine5 anti-mouse CD11c N418 FC
PE/Cyanine7 anti-mouse CD11c N418 FC
Brilliant Violet 605™ anti-mouse CD11c N418 FC
Alexa Fluor® 700 anti-mouse CD11c N418 FC
Pacific Blue™ anti-mouse CD11c N418 FC
APC/Cyanine7 anti-mouse CD11c N418 FC
PerCP/Cyanine5.5 anti-mouse CD11c N418 FC
PerCP anti-mouse CD11c N418 FC
Brilliant Violet 421™ anti-mouse CD11c N418 FC,IHC
Brilliant Violet 570™ anti-mouse CD11c N418 FC
Brilliant Violet 785™ anti-mouse CD11c N418 FC
Brilliant Violet 510™ anti-mouse CD11c N418 FC
Brilliant Violet 650™ anti-mouse CD11c N418 FC
Purified anti-mouse CD11c (Maxpar® Ready) N418 FC,CyTOF®
Alexa Fluor® 594 anti-mouse CD11c N418 IHC-F,3D IHC
PE/Dazzle™ 594 anti-mouse CD11c N418 FC
Spark NIR™ 685 anti-mouse CD11c N418 FC
Spark UV™ 387 anti-mouse CD11c N418 FC
Spark Red™ 718 anti-mouse CD11c N418 FC
Spark Blue™ 515 anti-mouse CD11c N418 FC
PerCP/Fire™ 806 anti-mouse CD11c N418 FC
Spark PLUS UV395™ anti-mouse CD11c N418 FC
Spark Blue™ 574 anti-mouse CD11c (Flexi-Fluor™) N418 FC
Spark PLUS B550™ anti-mouse CD11c N418 FC
APC/Fire™ 810 anti-mouse CD11c Antibody N418 FC
PE/Fire™ 640 anti-mouse CD11c Antibody N418 FC
Spark YG™ 581 anti-mouse CD11c (Flexi-Fluor™) N418 FC
Spark YG™ 593 anti-mouse CD11c (Flexi-Fluor™) Antibody N418 FC
Spark PLUS V475™ anti-mouse CD11c Antibody N418 FC
Go To Top Version: 1    Revision Date: 11-30-2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account